Leviathan Cannabis Group Inc Share Price Canadian Securities Exchange
Equities
CA61762Y1051
Pharmaceuticals
Sales 2022 | 842K 615K 49.22M | Sales 2023 | 35.34M 25.79M 2.06B | Capitalization | 219M 159M 12.77B |
---|---|---|---|---|---|
Net income 2022 | -4M -2.92M -234M | Net income 2023 | - 0 0 | EV / Sales 2022 | 150 x |
Net Debt 2022 | 8.9M 6.49M 520M | Net Debt 2023 | 3.32M 2.42M 194M | EV / Sales 2023 | 6.28 x |
P/E ratio 2022 |
-23.4
x | P/E ratio 2023 |
-238
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.12% |
Managers | Title | Age | Since |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 06/03/22 |
Director of Finance/CFO | - | 06/03/22 | |
Kamyar Hosseini
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 06/03/22 |
Rupalee Mehta
BRD | Director/Board Member | - | 06/03/22 |
Lucas Leone
BRD | Director/Board Member | - | 06/03/22 |
1st Jan change | Capi. | |
---|---|---|
+31.84% | 699B | |
+26.49% | 571B | |
-3.92% | 364B | |
+18.76% | 326B | |
+2.82% | 286B | |
+14.47% | 236B | |
+4.67% | 198B | |
-12.19% | 194B | |
-3.37% | 154B |